AI assistant
Sending…
Apyx Medical Corp — Director's Dealing 2014
Sep 23, 2014
34303_dirs_2014-09-23_f1ddf65c-4bc8-4caa-903f-a02e13cf0fa6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOVIE MEDICAL CORP (BVX)
CIK: 0000719135
Period of Report: 2014-09-19
Reporting Person: MAKRIDES ANDREW (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-09-19 | Common Stock | M | 25000 | $2.13 | Acquired | 624213 | Direct |
| 2014-09-19 | Common Stock | F | 12241 | $4.35 | Disposed | 611972 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-09-19 | Stock Option (Option to Buy) | $2.13 | M | 12759 | Acquired | 2014-09-23 | Common Stock (25000) | Direct |
Footnotes
F1: Reflects 12,241 shares withheld by the issuer at the market price of $4.35 per share less an exercise price of $2.13 per share to fund the cashless exercise of 25,000 options owned by the reporting person.
More from Apyx Medical Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 11
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Director's Dealing
2026
Mar 17
Annual Report
2026
Mar 10
Regulatory Filings
2026
Mar 10
Major Shareholding Notification
2026
Feb 13